Published in Am J Kidney Dis on September 01, 1999
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) (2010) 1.88
Prediction of urinary protein markers in lupus nephritis. Kidney Int (2005) 1.77
Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol (2003) 1.16
Role of early repeated renal biopsies in lupus nephritis. Lupus Sci Med (2014) 0.97
Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy. Pediatr Nephrol (2007) 0.95
Value of repeat biopsy in lupus nephritis flares. Lupus Sci Med (2014) 0.95
Diagnosis and treatment of lupus nephritis flares--an update. Nat Rev Nephrol (2012) 0.92
The kidney biopsy in lupus nephritis: is it still relevant? Rheum Dis Clin North Am (2014) 0.89
Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders. Lupus Sci Med (2015) 0.86
Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol (2012) 0.83
Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol (2004) 0.83
Treatment of proliferative lupus nephritis: a slowly changing landscape. Nat Rev Nephrol (2010) 0.79
Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis. Rheumatol Int (2011) 0.76
Chapter 12: Lupus nephritis. Kidney Int Suppl (2011) (2012) 0.75
A retrospective analysis of clinical presentation of lupus nephritis. Am J Med Sci (2011) 0.75
Do we still need renal biopsy in lupus nephritis? Reumatologia (2016) 0.75
Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis. PLoS One (2016) 0.75
Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance. Pediatr Rheumatol Online J (2015) 0.75
The value of repeat biopsy in lupus nephritis flares. Medicine (Baltimore) (2017) 0.75
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet (1999) 3.51
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol (2007) 2.30
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol (1998) 2.21
Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int (1997) 2.17
Lithium deintercalation in LiFePO4 nanoparticles via a domino-cascade model. Nat Mater (2008) 2.15
Hypnosis as sole anaesthesia for skin tumour removal in a patient with multiple chemical sensitivity. Anaesthesia (2013) 2.05
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86
A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med (1992) 1.81
Exacerbation of motor tic and induction of new tic by haloperidol use. West J Med (1992) 1.78
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Blood (1998) 1.71
Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int (2001) 1.64
Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant (1995) 1.57
"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int (1996) 1.49
Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine (2013) 1.48
High prevalence of silent gallstone disease in dialysis patients. Nephron (1994) 1.45
Values of the parameter immature reticulocyte fraction in elite athletes. Clin Lab Haematol (2004) 1.42
Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest (1994) 1.42
Gitelman syndrome: pathophysiological and clinical aspects. QJM (2010) 1.39
Microscopic hematuria diagnosis and management. Nephron (1996) 1.39
Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int (1995) 1.39
Regulation of base balance in bicarbonate hemofiltration. Int J Artif Organs (1994) 1.38
How to manage the dialysis patient with chronic viral hepatitis who is considered for renal transplantation. Nephrol Dial Transplant (1996) 1.38
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. J Hypertens (2000) 1.36
Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int (1995) 1.36
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001) 1.32
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32
A second genetic locus for autosomal dominant polycystic kidney disease. Lancet (1988) 1.29
Evidence-based careflow management systems: the case of post-stroke rehabilitation. J Biomed Inform (2002) 1.29
Neurological dysfunction associated with nonketotic hyperglycemia. Arch Neurol (1968) 1.26
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J (Clin Res Ed) (1987) 1.23
A patient workflow management system built on guidelines. Proc AMIA Annu Fall Symp (1997) 1.21
Cerebral oedema complicating treated non-ketotic hyperglycaemia. Lancet (1969) 1.21
Meta-analysis of the effect of the use of computer-based systems on the metabolic control of patients with diabetes mellitus. Diabetes Technol Ther (2001) 1.17
Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int (1995) 1.16
Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res (2000) 1.15
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis (2001) 1.15
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis (2008) 1.15
Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med (1986) 1.15
Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int (2001) 1.15
The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol (1991) 1.13
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis (2001) 1.13
Renal replacement therapy in the elderly. Q J Med (1989) 1.13
Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int (1988) 1.11
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant (1995) 1.11
Heart rate control in hypertensive patients treated by captopril. Br J Clin Pharmacol (1982) 1.10
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study. Diabetologia (2008) 1.07
Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol (1989) 1.07
A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation. Transplantation (1991) 1.07
Cutaneous abnormalities in uremic patients. Nephron (1985) 1.06
Factor VIII and chronic renal failure. Br Med J (1977) 1.06
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet (1996) 1.06
Immunohistochemical staining on hydroxyethyl-methacrylate-embedded tissues. J Histochem Cytochem (1983) 1.05
Folding and aggregation of designed proteins. Proc Natl Acad Sci U S A (1998) 1.04
Deciding when to intervene: a Markov decision process approach. Int J Med Inform (2000) 1.04
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04
Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) (2005) 1.04
Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet (1983) 1.04
Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol (1987) 1.02
Acquired dysfunction due to the circulation of "exhausted" platelets. Am J Med (1980) 1.02
Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients. Q J Med (1981) 1.02
Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand (1992) 1.01
Discovery of localized regions of excess 10-TeV cosmic rays. Phys Rev Lett (2008) 1.01
Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int (1983) 1.00
Activation of epileptogenic foci by hyperosmolality. Neurology (1967) 1.00
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant (1994) 1.00
Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation (2001) 0.99
Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study. Transplantation (1997) 0.99
Invited review: Dairy intake and bone health: a viewpoint from the state of the art. J Dairy Sci (2011) 0.99
Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis. Nephron (1983) 0.97
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab (2000) 0.97
EDTA-dependent pseudothrombocytopaenia: a 12-month epidemiological study. Scand J Clin Lab Invest (1988) 0.97
Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference. Clin Chem Lab Med (2000) 0.97
Hepatorenal syndrome. New perspectives in pathogenesis and treatment. Arch Intern Med (1993) 0.96